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Abstract
Background The timing of the risk factors cigarette
smoking, alcohol and obesity in the development of Bar-
rett’s esophagus (BE) and esophageal adenocarcinoma
(EAC) is unclear.
Aims To investigate these exposures in the aetiology of
BE and EAC in the same population.
Methods The cohort included 24,068 men and women,
aged 39–79 years, recruited between 1993 and 1997 into
the prospective EPIC-Norfolk Study who provided infor-
mation on anthropometry, smoking and alcohol intake. The
cohort was monitored until December 2008 and incident
cases identified.
Results One hundred and four participants were diag-
nosed with BE and 66 with EAC. A body mass index
(BMI) above 23 kg/m2 was associated with a greater risk of
BE [BMI C23 vs. 18.5 to \23, hazard ratio (HR) 3.73,
95 % CI 1.37–10.16], and within a normal BMI, the risk
was greater in the higher category (HR 3.76, 95 % CI
1.30–10.85, BMI 23–25 vs. 18.5 to [23 kg/m2). Neither
smoking nor alcohol intake were associated with risk for
BE. For EAC, all BMI categories were associated with risk,
although statistically significant for only the highest (BMI
[35 vs. BMI 18.5 to\23, HR 4.95, 95 % CI 1.11–22.17).
The risk was greater in the higher category of a normal
BMI (HR 2.73, 95 % CI 0.93–8.00, p = 0.07, BMI 23–25
vs. 18.5 to [23 kg/m2). There was an inverse association
with C7 units alcohol/week (HR 0.51, 95 % CI 0.29–0.88)
and with wine (HR 0.49, 95 % CI 0.23–1.04, p = 0.06,
drinkers vs. non-drinkers).
Conclusions Obesity may be involved early in carcino-
genesis and the association with EAC and wine should be
explored. The data have implications for aetiological
investigations and prevention strategies.
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Introduction
The incidence of esophageal adenocarcinoma (EAC) has
increased by fivefold over the last three decades and is the
sixth commonest cause of cancer death in the UK [1–3].
Barrett’s esophagus (BE), the metaplastic change of the
esophageal mucosa from squamous to a columnar type, is
an established risk factor for EAC, with the rate of
malignant change between 0.2 and 10 % per year [4–7].
The plausible aetiological risk factors for BE and EAC
include smoking, alcohol and obesity. The biological
mechanisms include carcinogenic chemicals in cigarettes
[8] and obesity, firstly accentuating reflux of both acid and
bile into the lower esophagus, and secondly being a source
of adipokines, which may be pathogenic [9]. Refluxed
gastric juice may damage the esophageal mucosa, exposing
the multi-potential stem cells in the basal layers to juice
constituents that stimulate abnormal differentiation [10].
Although alcohol could have a corrosive effect, polyphe-
nols present in wine have anti-oxidant properties and may
reduce DNA damage.
The proposed experimental mechanisms for carcino-
genesis need to be supported by population-based data. The
strongest such information is from prospective cohort
investigations, where risk factors are recorded prior to the
development of symptoms. This approach minimises the
recall bias for potential risk factors associated with case–
control studies. For BE and body mass index (BMI), there
are just two such cohort studies, one of which studied only
women [11] reporting a positive association in obese par-
ticipants. A second investigation found no effect in men,
but a positive association in women [12]. For EAC, it is
well documented that increasing obesity increases the risk
of cancer [13–16]. Both diseases need to be studied in the
same population to determine at which stage of carcino-
genesis BMI may operate. In cohort studies, cigarette
smoking doubles the risk of EAC [17, 18], whereas in the
sparse work in BE, it is former, rather than current smok-
ing, for which positive associations are reported [12, 19]. A
pooled analysis of two cohort and ten case–control studies
reported strong associations between cigarette smoking
with both esophageal adenocarcinoma and junctional ade-
nocarcinoma [20]. For alcohol, there are a limited number
of prospective studies which report no associations for
either BE or EAC [12, 17, 18] and no associations
according to the specific intakes of either beer, wine or
spirits.
The study’s aims were to clarify whether smoking, BMI
and alcohol are associated with the development of both
BE and EAC. To the best of our knowledge, this would be
the first time both have been simultaneously examined in
the same population in a prospective study. BMI within the
range 18.5 to\25.0 kg/m2 will be assessed to see if the risk
varies across the conventional definition of a normal BMI.
The World Health Organisation recommends a BMI of
23 kg/m2 as a cut-point for public health actions [21]. The
intakes of specific types of alcohol will be studied. Inves-
tigating these exposures will help clarify if they should be
measured in future aetiological studies, which may have
implications for cancer prevention.
Methods
We report results from 24,068 participants (54 % women)
aged 39–74 years recruited into the European Prospective
Investigation of Cancer-Norfolk (EPIC-Norfolk) study
between 1993 and 1997, who were initially without diag-
nosed BE or EAC. Participants were registered in general
practices in rural, suburban and inner city areas and com-
pleted questionnaires at baseline providing information on
cigarette smoking and alcohol intake. Alcohol consumption
was recorded in a food frequency questionnaire which
listed different alcoholic beverages and the frequency of
intake at recruitment, aged 20 years and aged 30 years.
Participants attended baseline health checks at recruitment
where their height and weight were measured by nurses,
using standard protocols, from which their BMI was cal-
culated (kg/m2).
Following recruitment, the cohort was monitored until
December 2008 to identify incident cases of both BE
(diagnosed at gastroscopy after referral predominantly for
reflux symptoms) and EAC. This was achieved by match-
ing subject identifiers on the histology database at the
Norfolk and Norwich University Hospital (NNUH) with
the EPIC database. Further cases of EAC were retrieved
from the Eastern Region Cancer Registry. In total, 95 % of
the cohort received their clinical care for BE at the NNUH,
and for EAC the figure is approximately 97.5 %. Twenty
years after the cohort commenced recruitment, 94.6 % of
those still alive have local residential postcodes. The cohort
was monitored until either the end of study date, date of
death or loss to follow-up. The medical records of all
identified participants were reviewed by two clinicians
(MY and EC) to ascertain the dates of diagnosis, endo-
scopic appearances, and the length of the affected segment.
For BE to be included, the gastroscopy report required the
endoscopist to firstly document characteristic endoscopic
appearances and, secondly, the pathologist to report
columnar metaplasia of either intestinal, gastric or mosaic
type. Cases were excluded that had either microscopic
columnar metaplasia without endoscopic changes or no
evidence of BE at a subsequent gastroscopy. Cases of
gastric metaplasia were reviewed to ensure that macro-
scopic BE was seen above the esophagogastric junction.
The medical notes and EPIC questionnaires were reviewed
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to ensure that there was no previous history of BE or EAC
prior to enrolment into EPIC. Cases were excluded if BE
was diagnosed within the first year after recruitment or
6 months for EAC. In this study, we could not detect
asymptomatic Barrett’s esophagus as the population was
not screened endoscopically.
In the analysis, hazard ratios (HR) were estimated using
Cox regression, for BE and EAC separately, adjusted for
age at recruitment and gender. Cigarette smoking status
was classified as ‘‘current,’’ ‘‘never’’ or ‘‘former’’ smoking.
Alcohol consumption was divided into the standard cate-
gories (units per week): none,[0 to\7, C7 to\14, C14 to
\21, C21 to \28 and C28. BMI (kg/m2) was classed into
18.5 to\23 (lower normal), 23 to\25 (upper normal), C25
to \30 (overweight), C30 to \35 (obese) and C35 (mor-
bidly obese). Participants with a BMI of\18.5 kg/m2 were
excluded as this value is defined as a below normal BMI
and unrepresentative of the general population. A baseline
category of BMI 18.5–23 kg/m2 was chosen, rather than
\25 kg/m2, to study the risk across the normal BMI range.
A second analysis included smoking, alcohol intake and
BMI in the same model.
Results
During follow-up, 284 potential cases of BE were identi-
fied from histopathological data, although after review of
the medical notes, only 155 (55 %) were eligible. A total of
129 (45 %) participants were initially excluded (‘‘Appen-
dix’’), the commonest reason being no evidence of endo-
scopically visible BE at the first gastroscopy after
reviewing the case notes. A further 51 (18 %) were then
excluded who had either a diagnosis for a previous cancer
outside the esophagus (which could influence the repre-
sentativeness of the exposures) or with incomplete baseline
data. For the 104 confirmed cases of BE, the median age at
diagnosis was 67.0 years (range 41.3–84.4 years, 79.8 %
men; Table 1), diagnosed after a median follow-up time of
6.2 years (range 1.1–13.3 years). The median length of BE
at the initial diagnosis was 5 cm (range 1–10 cm), with
93 % having metaplasia, but no dysplasia. The metaplasia
was classed as intestinal 70 %, gastric 9 %, mosaic 16 %
and not reported 5 %. In BE patients, 77 % had reflux
symptoms at the time of gastroscopy, with 73 % having a
hiatal hernia. The remaining 23 % of patients were referred
for investigation of iron deficiency anaemia. For EAC,
there were 70 incident cases, of which four were excluded
due to incomplete baseline health check data. Of the 66
cases, the median age at diagnosis was 73 years (range
52–86 years, 83.3 % men; Table 2) with a median time
between recruitment and diagnosis of 6.2 years (range
0.6–11.8 years). Information on the tumour site was
available for 94 % of patients, with 87 % involving the
gastro-esophageal junction. There were no cases with a
BMI less than 18.5 kg/m2, but 117 controls (0.49 % of the
cohort). There was at least 97 % completeness of data for
all of the three risk factors in both conditions. The number
of cases of both BE and EAC were similar to that estimated
using information from two large UK databases [22, 23].
None of the EAC cases included had a prior history of
screening or surveillance for BE. However, five of the
incident BE cases did progress to EAC during follow-up.
These were not included in the cancer analysis as they may
have had life-style advice/interventions following the BE
diagnosis which influenced their EAC risk.
Cases of BE were more likely than controls to be older,
male, smokers and have greater BMIs (Table 1). In the
multivariate analysis, there was a threshold association
with all increasing categories of BMI at recruitment having
a greater than threefold increased risk of BE (e.g. BMI C30
to \35 vs 18.5 to \23 kg/m2, HR 3.22, 95 % CI
1.04–10.02, p = 0.04; Table 3). This effect persisted when
a level of 18.5 to \23 kg/m2 was compared to a BMI of
C23 (HR 3.73, 95 % CI 1.37–10.16). Similarly, in men, a
BMI of C23 kg/m2 was associated with an increased risk
(HR 2.44, 95 % CI 0.89–6.66, p = 0.08), but there were
insufficient numbers for this analysis in women. There
were no statistically significant effects of smoking or
alcohol at recruitment, respectively, on the risk of BE. The
results were similar for each risk factor when the other two
co-variants were included in the model. The attributable
fraction for a BMI C23 kg/m2 was 70 %, i.e. the percent-
age of all cases with a BMI of this level. For alcohol intake,
when participants were aged 20 and 30 years, no signifi-
cant associations were seen in individual categories or for
Table 1 Characteristics of participants with and without confirmed
Barrett’s esophagus
Variable Cases
(n = 104)
Controls
(n = 23,876)
p value
Age at recruitment
(years, median, range)
60.3 (40.1–76.1) 58.7
(39.5–77.1)
\0.01
Age at diagnosis (years,
median, range)
67.0 (41.3–84.4) – n/a
Gender (% male) 79.8 % 46.1 % \0.001
BMI (kg/m2, median
and range)
26.8 (21.1–39.4) 25.9
(18.5–53.9)
\0.02
Smoking
Never smoked 13.5 % 46.1 % 0.001
Former smoker 55.8 % 42.2 % 0.005
Current smoker 30.8 % 11.7 % 0.58
Alcohol consumption
(units per week,
median, range)
5.5 (0–50.0) 3.5
(0–121.0)
\0.07
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the respective trends (HR 1.05, 95 % CI 0.91–1.22 & HR
1.07, 95 % CI 0.92–1.23). Approximately half the cohort
provided information on the type of alcohol consumed, and
comparing non-drinkers to drinkers, no associations were
seen for wine consumption (HR 0.90, 95 % CI 0.48–1.69),
beer (HR 1.55, 95 % CI 0.73–3.29) or spirits (HR 0.68,
95 % CI 0.38–1.22).
Cases of EAC were more likely than controls to be older
at recruitment, male and smokers (Table 2). All categories
of BMI at recruitment were positively associated with an
increased risk of EAC, although only the highest was sta-
tistically significant (BMI C35 vs. BMI \23 kg/m2, HR
4.95, 95 % CI 1.11–22.17, p = 0.04; Table 4). There were
no associations with smoking status, nor any individual
category of alcohol intake at baseline, although there was
an inverse trend with increasing categories of intake (HR
0.83, 95 % CI 0.67–1.03, p = 0.09). Alcohol intake of 7
units/week or more, compared to less, was inversely
associated with risk (HR 0.51, 95 % CI 0.29–0.88,
p = 0.02), with inverse associations in both sexes (men HR
0.54, 95 % CI 0.30–0.96 & women HR 0.31, 95 % CI
0.04–2.44). For alcohol intake at age 20 years and age
30 years, no significant associations were seen for cate-
gories or for the respective trends (HR trend = 1.04, 95 %
CI 0.86–1.26, HR trend = 1.02, 95 % CI 0.84–1.24). For
the sub-types of alcohol, comparing non-drinkers to
drinkers, an inverse association of borderline statistical
significance, was detected for wine consumption (HR 0.49,
95 % CI 0.23–1.04, p = 0.06), but not beer (HR 1.91,
95 % CI 0.70–5.18) or spirits (HR 0.68, 95 % CI
0.33–1.39). The magnitudes of all associations were similar
when smoking, body mass index and alcohol were all
included in the model. For BMI, the analysis was repeated
excluding cases diagnosed less than a year within recruit-
ment to exclude the possibility that subjects were already
beginning to lose weight. This accentuated the results for
all BMI categories, although only the highest was statisti-
cally significant (BMI C35 vs. BMI \23 kg/m2, HR 6.65,
95 % CI 1.34–33.02, p = 0.02).
In a post hoc analysis, associations with waist/hip ratio
(WHR) were investigated as WHR may be more repre-
sentative of abdominal obesity than BMI [24, 25]. Here we
categorised both genders, according to the gender specific
definitions of WHR, into one of three grouped weight
categories (normal, overweight & obese) and calculated a
trend across categories [24]. This showed a significant
trend for both BE (RR trend = 1.35, 95 % CI 1.03–1.76,
p = 0.03) and EAC (RR trend = 1.43, 95 % CI 1.03–2.00,
p = 0.03).
Discussion
A main finding of this study was that in each category of
BMI greater than 23 kg/m2, there was at least a tripling of
the risk of BE, with higher BMIs associated with more than
two-thirds of cases. For EAC, positive associations were
seen in each category of BMI, although this was only
statistically significant in the morbidly obese (BMI C35).
The conventional definition of a ‘‘normal’’ BMI is 18.5 to
\25.0 kg/m2 and the increased risk suggested in the upper
normal range, i.e. 23 to\25 kg/m2, in both BE and EAC is
a concern, although the baseline BMI category in both
included only four cases. This raises the issue of whether
the definition of a ‘‘normal’’ BMI should be reconsidered.
The rationale for including this range in the analysis is the
WHO expert report [21] which recommended reporting
disease risks in the category of 18.5–23 kg/m2 for potential
public health action. The reasons are unknown for the
positive associations between BMI and both BE and EAC,
suggested in a threshold level above 23 kg/m2, rather than
a dose-dependent manner with increasing BMI. Hypothet-
ically, if carcinogenesis occurs through contact of constit-
uents of the refluxate with the mucosa linked with BMI,
this process may be initiated above a certain level of BMI
and then other factors are involved in cancer progression.
The findings from our work on BE are supported by other
prospective cohorts [11, 12], although we have reported
Table 2 Characteristics of participants with and without confirmed esophageal adenocarcinoma (EAC)
Variable Cases (n = 66) Controls (n = 24,000) p value
Age at recruitment (years, median, range) 67.0 (46.7–76.3) 58.8 (39.5–79.1) \0.001
Age at diagnosis (years, median, range) 73 (52–86) –
Gender (% male) 83.3 % 46.3 % \0.001
BMI (kg/m2, median and range) 26.5 (20.1–42.8) 25.9 (18.5–53.9) 0.24
Smoking
Never smoked 27.7 % 46.0 % 0.003
Former smoker 58.5 % 42.3 % 0.009
Current smoker 13.8 % 11.7 % 0.59
Alcohol consumption (units per week, median and range) 2.5 (0.0–44.0) 3.5 (0–121) 0.38
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this relationship in men with BE for the first time. In EAC,
a US prospective investigation of 308,692 men and
211,702 women, documented a positive association with
BMI, even in the normal range, as did our study in the UK
[26]. In the former, the incremental increased risk of EAC
per BMI unit was greater across the normal range than
within the overweight and obese categories [26]. The rise
in risk of EAC within the normal definition of BMI, now
reported in two studies, would have implications for public
health policy if the association is causal. There are several
plausible biological mechanisms, in addition to attenuating
reflux, for how an increased BMI may be involved in the
development of BE and EAC. Visceral adipose tissue is
metabolically active, increasing levels of interleukin-6,
leptin, TNF-alpha and insulin-like growth factor-1, which
may be involved in pathogenesis [9]. Leptin stimulates cell
proliferation and inhibits apoptosis in Barrett’s esophagus-
derived EAC cells which promotes the accumulation and
persistence of genetic abnormalities [27]. In animal mod-
els, dietary animal fat increased the proportion of taurine
conjugates in bile [28], which may damage cellular or
mitochondrial membranes leading to proliferation.
This study found weak positive associations between
smoking and BE or EAC, although these were not sta-
tistically significant. There were suggestions of positive
trends in both conditions and larger numbers with longer
follow-up are required to accrue more cases to provide
clarification. Previous studies reported that smoking
increased the risk of EAC [17, 18], although in BE it is
former smoking which is important [12, 19]. The reasons
for this are uncertain, but a possibility is that those with
BE had long-standing symptoms such as reflux before
diagnosis which were exacerbated by cigarettes, and
hence stopped smoking. For alcohol, we documented an
inverse association for trend of borderline statistical
significance (p = 0.09) between an increased intake and
EAC. For participants drinking seven or more units per
week, compared to those drinking less, there was a
significant halving of the risk. This was due to alcohol
from wine, rather than beer or spirits, which suggests
any potential benefit is due to components in the wine,
rather than the alcohol itself. No association was seen
with BE which suggests any protective effect of wine
may be in preventing the malignant transformation of
metaplastic epithelium. The inverse association with
wine and EAC may be explained by participants reduc-
ing their intake to ameliorate symptoms before diagnosis,
although this is less likely as no such associations were
seen for beer or spirits. Any benefit of alcohol may be
due to that consumed in later life as no associations were
Table 3 Relationship between body mass index, alcohol intake and smoking status and the risk of developing Barrett’s esophagus (BE)
BMI (kg/m2)b Cases (n = 104) Controls (n = 23,829) Hazard ratio (95 % CI)a p value
18.5 to \23 4 4,206 1.00 –
23 to \25 24 5,113 3.76 (1.30–10.85) 0.01
25 to \30 62 10,861 3.87 (1.40–10.68) \0.01
30 \ 35 12 2,951 3.22 (1.04–10.02) 0.04
C35 2 698 3.21 (0.59–17.57) 0.18
Alcohol (units per week)c Cases (n = 103) Controls (n = 23,633) Hazard ratio (95 % CI)a p value
No alcohol 15 3,079 1.00 –
[0 to \7 39 12,091 0.61 (0.33–1.11) 0.10
7 to \14 24 4,536 0.84 (0.43–1.61) 0.59
14 to \21 9 2,005 0.64 (0.28–1.49) 0.30
21 to \28 9 924 1.09 (0.45–2.61) 0.85
[28 units 7 998 0.84 (0.34–2.10) 0.71
Smoking statusd Case (n = 104) Controls (n = 23,670) Hazard ratio (95 % CI)a p value
Never smoked 32 10,909 1.00 –
Former smoker 58 9,995 1.38 (0.88–2.16) 0.16
Current smoker 14 2,766 1.57 (0.83–2.96) 0.17
a Adjusted for age and gender at recruitment
b Trend across categories of BMI HR = 1.20 (95 % CI 0.97–1.49, p = 0.09)
c Trend across categories HR = 1.04 (0.90–1.21, p = 0.60)
d Trend across categories HR = 1.28 (0.95–1.72, p = 0.11)
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reported with that consumed at age 20 or 30 years. The
BEACON Consortium, a pooled analysis of two cohort
investigations and nine case–control studies, reported no
overall effects of increasing intake of alcohol, although
there were inverse associations with a moderate intake
(0.5 to \1 drink/day) and EAC (OR 0.63, 95 % CI
0.41–0.99), and junctional adenocarcinomas (OR 0.78,
95 % CI 0.62–0.99) [29]. Previous prospective studies,
which minimise recall biases, have not documented any
associations with either EAC [17, 18] or BE [12],
including according to the specific intakes of beer, wine
and spirits. However, the categories of alcohol intake
analysed, and possibly the units of consumption, varied
between these and our work, which may explain the
discrepancies.
The strengths of this study were that there were
minimal selection or recall biases, a methodological
problem of case–control work. Furthermore, the Norfolk
population is geographically stable so follow-up bias was
reduced. All the cases were confirmed by reviewing the
clinical notes for both endoscopic and histological cri-
teria. There are limitations to our work, in that although
all cancer cases will present, the BE cases were diag-
nosed as a result of symptoms. BE is also present in
both asymptomatic individuals [30] and in those with
reflux symptoms who do not seek medical help, two
groups we could not identify or investigate. Additionally,
not all symptomatic individuals had gastroscopy, as this
will have been done according to individual need and
referral practices. Whether the aetiology of both
asymptomatic Barrett’s esophagus and those not pre-
senting or referred for investigation is different in
patients diagnosed through investigation of reflux symp-
toms is unknown. A further limitation is that there may
be residual confounding for BMI, including nutrients,
and this work will progress to investigate diet. Only one
measurement of risk factors was used, namely that at
baseline and these may alter over time. However, such
measurement error would result in an under-estimate of
any true effect, rather than spurious over-estimates.
Finally, the number of cases was relatively small, so the
precision of the estimates was reduced and small asso-
ciations may have gone undetected.
The increased risk within the upper limits of the
normal range of BMI is a concern and suggests that the
categories of BMI should perhaps be reconsidered. There
was an inverse relationship between alcohol consumption
of more than seven units per week and EAC, for which
possible biological mechanisms need to be explored. To
the best of our knowledge, this is the first study to report
these three factors directly in both BE and EAC in the
same population, which provides information on which
Table 4 Relationship between body mass index, alcohol intake and smoking status and the risk of developing esophageal adenocarcinoma
BMI (kg/m2)b Cases (n = 65) Controls (n = 23,906) Hazard ratio (95 % CI)a p value
18.5 to \23 4 4,216 1.00 –
23 to \25 19 5,131 2.73 (0.93–8.00) 0.07
25 to \30 32 10,932 1.82 (0.64–5.17) 0.26
30 to \35 7 2,927 1.68 (0.49–5.75) 0.41
C35 3 700 4.95 (1.11–22.17) 0.04
Alcohol (units per week)c Cases (n = 66) Controls (n = 23,755) Hazard ratio (95 % CI)a p value
No alcohol 8 3,104 1.00 –
[0 to \7 40 12,135 1.34 (0.63–2.88) 0.45
7 to \14 10 4,563 0.73 (0.28–1.86) 0.50
14 to \21 3 2,015 0.47 (0.12–1.79) 0.27
21 to \28 2 930 0.59 (0.12–2.80) 0.51
[28 3 1,008 0.83 (0.22–3.18) 0.79
Smoking statusd Cases (n = 66) Controls (n = 23,795) Hazard ratio (95 % CI)a p value
Never smoked 18 10,951 1.00 –
Former smoker 39 10,063 1.27 (0.71–2.27) 0.41
Current smoker 9 2,781 1.82 (0.81–4.09) 0.14
a Adjusted for age and gender at recruitment
b Trend across categories HR = 1.10 (0.83–1.44, p = 0.51)
c Trend across categories HR = 0.83 (0.67–1.03, p = 0.09)
d Trend across categories HR = 1.34 (0.90–1.99, p = 0.15)
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stage of carcinogenesis they may act. Body mass index
seems to be related to at least the development of BE,
and perhaps constituents of wine may prevent meta-
plastic progression to cancer. Our results support, firstly,
measuring BMI in future aetiological studies including
across the normal range of BMI and, secondly, according
to the standardised intakes of alcohol. If the associations
are causal, then reducing population BMI and giving
recommendations on alcohol intake may help prevent a
cancer which is increasing in incidence.
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